Morristown, N.J.-based Atlantic Health System named Mohamad Cherry, MD, medical director of its hematology and cellular therapy programs, it said Feb. 23.
The Latest
Yale Cancer Center is partnering with the National Brain Tumor Society to launch a flagship research initiative focused on DNA damage, the cancer center said Feb. 22.
The Barbara Ann Karmanos Cancer Institute in Detroit is collaborating with Lifeguard Health Networks to pilot a digital care platform for cancer patients.
These six oncologists joined new practices or received new appointments over the last few weeks.
The American Cancer Society's National Consortium for Cancer Screening and Care outlined nine recommendations to bring screening rates back to pre-pandemic levels in a Feb. 16 report.
Here are five moves reported by Becker's about the University of Texas MD Anderson Cancer Center since Jan. 10:
AstraZeneca and Daiichi Sankyo's Enhertu breast cancer drug significantly helped patients with HER2-low metastatic breast cancer in its phase 3 clinical trial, AstraZeneca said Feb. 21.
Yale Cancer Center invested $1.5 million to improve its hematology/oncology fellowship program, it said Feb. 18.
Rutgers Cancer Institute of New Jersey named Sanjay Goel, MD, director of its investigational therapeutics program, it said Feb. 16.
The University of Texas MD Anderson Cancer Center was awarded $31.7 million from the Cancer Prevention and Research Institute of Texas, the center said Feb. 16.